1614, 1592, 1473, 1318, 1252, 1206, 1109, 1018, 827, 790 and
685; δH (400 MHz; CDCl3) 3.88 (3H, s, CH3), 3.98 (3H, s, CH3),
4.09 (2H, br s, NH2), 6.29 (1H, dd, J4,3 8.5 and J4,6 2.3, 4-H),
6.31 (1H, d, J6,4 2.3, 6-H), 6.94 (1H, ddd, J6Ј,5Ј 8.8, J6Ј,2Ј 2.5 and
J6Ј,4Ј 0.9, 6Ј-H), 7.36 (1H, dd ≈ t, J5Ј,6Ј 8.8 and J5Ј,4Ј 7.8, 5Ј-H),
7.37 (1H, dd ≈ d, J2Ј,6Ј 2.5 and J2Ј,4Ј ≈ 0.3, 2Ј-H), 7.45 (1H,
ddd ≈ dd, J4Ј,5Ј 7.8, J4Ј,6Ј 0.9 and J4Ј,2Ј ≈ 0.3, 4Ј-H) and 7.70 (1H,
d, J3,4 8.5, 3-H); m/z (ISP) 248 (MHϩ, 100%) and 135 (8); m/z
258.1241 (M ϩ Hϩ. C14H16N3O2 requires m/z, 258.1243).
(1H, s, PhCH), 5.72 (1H, s, PhCH), 7.09–7.13 (1H, m, Ph),
7.21–7.25 (2H, m, Ph), 7.28–7.32 (2H, m, Ph), 7.38–7.46 (10H,
m, Ph), 7.81 (1H, br s, NH), 7.93 (1H, br s, NH), 8.50 (1H, br s,
NH) and 8.89 (1H, br s, NH); δC (100.6 MHz; d6-DMSO,
extract of data) 34.35 (PhCH), 67.87 (6A- and 6B-C), 71.05,
71.30, 75.83 and 75.95 (4A-, 4B-, 5A- and 5B-C), 93.08 and 93.65
(2A- and 2B-C), 101.62 (PhCH), 101.80 (PhCH), 168.4 and
170.80 (3A- and 3B-C), 184.86 and 185.57 (1A- and 1B-C); m/z
(ISP) 605 (MNaϩ, 49%), 583 (MHϩ, 100) and 336 (36); m/z
583.2082 (MHϩ. C33H31N2O8 requires m/z, 583.2080).
4,6-O-(R)-Benzylidene-1,2-dideoxy-1-(ß-naphthylamino)-D-
erythro-hex-1-enopyranos-3-ulose 11
(2R,3R,5S)-2,3,5,10-Tetrahydro-3-hydroxy-2-hydroxymethyl-5-
phenylpyrano[2,3-b]quinolin-4-one 18
To a solution of nitro enone 1 (200 mg, 0.72 mmol) in CH2Cl2
(3 cm3) were added, at 0 ЊC, 3-(dimethylamino)anisole 16 (106
mm3, 0.72 mmol) followed by 2-naphthylamine (206 mg, 1.44
mmol). The dark red suspension was stirred for 1 h at 0 ЊC and
for 1 h at rt. After addition of DMSO (3 cm3) the suspension
was evaporated under reduced pressure, and the dark syrup
was purified by chromatography (toluene–acetone 2:1, then
toluene–acetone 1:1) to give N,O-ketal 11 as a light brown solid
(147 mg, 55%); [α]D20 ϩ424 (c 0.40 in DMSO); νmax (MIR)/cmϪ1
3260, 3060, 1635, 1600, 1547, 1375, 1273, 1210, 1137, 1012, 822,
737 and 697; δH (250 MHz; d6-DMSO) 4.08–4.17 (1H, m, 6-Hb),
4.45–4.58 (3H, m, 4-H, 5-H and 6-Ha), 4.83 (1H, s, 2-H), 5.75
(1H, s, PhCH), 7.38–7.54 (8H, m, ArH), 7.71 (1H, br s,
ArH), 7.86–7.92 (3H, m, ArH) and 9.99 (1H, s, NH); m/z (EI)
373 (Mϩ, 17%), 211 (42), 183 (48), 143 (61), 115 (28) and 105
(PhCOϩ, 100); m/z 374.1396 (M ϩ Hϩ. C23H20NO4 requires
m/z, 374.1392).
To N,O-ketal 4 (85 mg, 0.263 mmol) and benzaldehyde (26.6
mm3, 0.263 mmol) was added TFA (1 cm3) at rt, and the solu-
tion was stirred for 24 h and concentrated at rt under reduced
pressure. Pyridine (0.15 cm3) was added to the syrup and
removed by evaporation under reduced pressure. The residue
was chromatographed twice (toluene–EtOH 9:1 and CH2Cl2–
MeOH 12:1) to give pyranoquinolinone 18 as a colourless solid
(31 mg, 36%). The solid was dissolved in boiling ethyl acetate–
CH2Cl2–MeOH 4:1:1, and the solution was slightly concen-
trated. Crystallization took place overnight at rt; mp 254 ЊC
(from ethyl acetate–CH2Cl2–MeOH); [α]D20 ϩ379 (c 0.36 in
DMSO) (Found: C, 70.22; H, 5.21; N, 4.19. C19H17NO4 requires
C, 70.58; H, 5.30; N, 4.30%); νmax (MIR)/cmϪ1 3250, 2935, 1600,
1569, 1521, 1479, 1452, 1240, 1038, 865, 745 and 696; δH (400
MHz; d6-DMSO) 3.74 (1H, ddd, J1Јb,1Јa 12.4, J1Јb,OH 6.0, J1Јb,2
5.5, 1Ј-Hb), 3.88 (1H, ddd, J1Јa,1Јb 12.4, J1Јa,OH 4.5 and J1Јa,2 2.0,
1Ј-Ha), 4.02 (1H, dd, J3,2 12.2 and J3,OH 4.4, 3-H), 4.14 (1H, ddd,
J2,3 12.2, J2,1Јb 5.1 and J2,1Јa 2.0, 2-H), 4.97 (1H, dd, JOH,1Јa 4.5
and JOH,1Јb 6.0, OH), 5.10 (1H, s, 5-H), 5.44 (1H, d, JOH,3 4.4,
OH), 6.91–6.95 (1H, m, ArH), 6.98–7.00 (1H, m, ArH), 7.08–
7.13 (2H, m, ArH), 7.18–7.36 (5H, m, Ph) and 10.40 (1H, s,
NH); m/z (ISP) 324 (MHϩ, 100%); m/z 324.1232 (M ϩ Hϩ.
C19H18NO4 requires m/z, 324.1236).
4,6-O-(R)-Benzylidene-1,2-dideoxy-1-(3-phenoxyphenylamino)-
D-erythro-hex-1-enopyranos-3-ulose 12
To a solution of nitro enone 1 (50 mg, 0.180 mmol) in CH2Cl2
(1.3 cm3) at 0 ЊC were added 3-(dimethylamino)anisole 16 (26.4
mm3, 0.180 mmol) and 3-phenoxyaniline (66.7 mg, 0.36 mmol).
The red solution was stirred for 1 h at 0 ЊC and for 1 h at rt.
After addition of a few drops of MeOH and dilution with
CH2Cl2–MeOH 40:1, the solution was chromatographed using
CH2Cl2–MeOH 40:1 as eluent to give N,O-ketal 12 as a beige
solid (55 mg, 74%); [α]D20 ϩ334 (c 0.32 in DMSO); νmax (Nujol)/
cmϪ1 3448, 2954, 2854, 1649, 1616, 1598, 1578, 1486, 1228,
1100, 980, 757 and 695; δH (250 MHz; d6-DMSO) 4.01 (1H,
dd ≈ t, J6b,6a 9.2 and J6b,5 9.2, 6-Hb), 4.33 (1H, ddd, J5,4 11.2, J5,6b
9.2 and J5,6a 4.5, 5-H), 4.44 (1H, dd, J6a,6b 9.2 and J6a,5 4.5,
6-Ha), 4.50 (1H, d, J4,5 11.2, 4-H), 4.72 (1H, s, 2-H), 5.70 (1H, s,
PhCH), 6.74–6.77 (1H, m, ArH), 6.81–6.82 (1H, m, ArH),
6.96–7.00 (1H, m, ArH), 7.05–7.08 (2H, m, ArH), 7.19–7.23
(1H, m, ArH), 7.31–7.48 (8H, m, Ph and ArH) and 9.84 (1H, s,
NH); m/z (ISP) 479 (MNaϩ ϩ CH3CN, 29%), 454 (MKϩ, 16),
438 (MNaϩ, 7) and 416 (MHϩ, 100); m/z 416.1495 (M ϩ Hϩ.
C25H22NO5 requires m/z, 416.1498).
(2R,3R,5S)-2,3,5,10-Tetrahydro-3-hydroxy-2-hydroxymethyl-7-
methyl-5-phenylpyrano[2,3-b]quinolin-4-one 19S and (2R,3R,
5R)-2,3,5,10-tetrahydro-3-hydroxy-2-hydroxymethyl-7-methyl-
5-phenylpyrano[2,3-b]quinolin-4-one 19R
(a) To N,O-ketal 9 (152 mg, 0.451 mmol) and benzaldehyde (46
mm3, 0.45 mmol) was added TFA (1.5 cm3) at rt. The solution
was stirred for 24 h and evaporated at rt under reduced
pressure. Pyridine (0.5 cm3) was added to the residue and
evaporated at rt. The residue was purified by chromatography
on silica gel (toluene–EtOH 10:1) to give pyranoquinolinones
19R/S as a colourless solid (95 mg, 63%, R:S 1:5).
(b) 19S was obtained as a by-product in the preparation of 30
(see below).
19R/S: νmax (MIR)/cmϪ1 3380, 3220, 1622, 1606, 1571, 1524,
1490, 1153, 1038, 901, 812, 720 and 700; δH (250 MHz; d6-
DMSO) 2.13 (0.5 H, R-CH3), 2.16 (2.5H, s, S-CH3), 3.66–3.91
(2H, m, 1Ј-H2), 3.99 (1H, dd, 3-H), 4.11 (0.83H, ddd, 2S-H),
4.30 (0.17H, ddd, 2R-H), 4.97 (0.83H, dd, J 6.0, J 5.5, OHS),
5.04 (1H, s, PhCH), 5.07 (0.17H, dd, OHR), 5.20 (0.83H, d,
J 4.4, OHS), 5.44 (0.17H, d, J 4.8, OHR), 6.83–6.96 (2H, m,
ArH), 6.99 (1H, s, ArH), 7.04–7.12 (1H, m, Ph), 7.18–7.21
(4H, m, Ph), 10.10 (0.17H, s, NHR) and 10.33 (0.83H, s,
NHS); m/z (ISP) 401 (MNaϩ ϩ CH3CN, 16%) and 338
(MHϩ, 100); m/z 338.1386 (M ϩ Hϩ. C20H20NO4 requires m/z,
338.1392).
Bis[1-amino-4,6-O-(R)-benzylidene-1,2-dideoxy-D-erythro-hex-
1-enopyranos-3-ulose-2-yl](phenyl)methane 17
To a solution of 6 (30 mg, 0.121 mmol) and benzaldehyde (12.1
mm3, 0.121 mmol) in dry THF (0.7 cm3) at rt was added
ZnCl2ؒEt2O (2.2 M in CH2Cl2; 55 mm3, 0.12 mmol). After stir-
ring of the mixture at rt for 72 h, triethylamine (50 mm3, 0.36
mmol), THF (4 cm3) and DMSO (0.6 cm3) were added, and the
solution was evaporated under reduced pressure. The residue
was chromatographed twice using CH2Cl2–MeOH 9:1 and
toluene–acetone 4:1 as eluents to afford 17 as a colourless solid
(30 mg, 85%); [α]D20 ϩ122 (c 0.15 in DMSO) (Found: C, 67.48; H,
5.06; N, 4.55. C33H30N2O4 requires C, 68.03; H, 5.19; N, 4.81%);
νmax (MIR)/cmϪ1 3321, 3085, 2868, 1689, 1654, 1567, 1528, 1450,
1271, 1107, 1068, 958, 759 and 693; δH (400 MHz; d6-DMSO)
4.04 (2H, dd ≈ t, 6-HAb and 6-HBb), 4.41–4.61 (6H, m, 4-HA,
4-HB, 5-HA, 5-HB, 6-HAa and 6-HBb), 5.25 (1H, s, PhCH), 5.70
Compound 19S: [α]D20 ϩ281 (c 0.20 in DMSO); νmax (MIR)/
cmϪ1 3400, 3280, 2960, 1622, 1606, 1568, 1486, 1163, 1031, 901,
809, 720 and 693; δH (250 MHz; d6-DMSO) 2.16 (3H, s, CH3),
3.71 (1H, ddd, J1Јb,1Јa 12.1, J1Јb,OH 6.0 and J1Јb,2 4.9, 1Ј-Hb), 3.86
(1H, ddd, J1Јa,1Јb 12.1, J1Јa,OH 5.7 and J1Јa,2 1.9, 1Ј-Ha), 4.00 (1H,
dd, J3,2 11.2 and J3,OH 4.4, 3-H), 4.11 (1H, ddd, J2,3 11.2, J2,1Јb
4.9 and J2,1Јa 1.9, 2-H), 4.97 (1H, dd, JOH,1Јb 6.0 and JOH,1Јa 5.7,
758
J. Chem. Soc., Perkin Trans. 1, 2000, 753–762